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SummaryEspH, a protein secreted by the diarrheagenic pathogen enteropathogenic *Escherichia coli* into intestinal epithelial cells, sequesters Rho guanine nucleotide exchange factors and inhibits Rho guanosine triphosphatases. These EspH effects cause desmosomal perturbations and loss of epithelial barrier integrity, and contribute to bacterial persistence in the intestine.

The intestinal epithelial monolayer facilitates absorption of nutrients and fluids, and, simultaneously, serves as a barrier against the entry of harmful intraluminal components such as bacteria and toxins into the underlying tissue.[@bib1] The paracellular space between adjacent intestinal epithelial cells (IECs) is bridged by protein complexes including tight junctions (TJs), adherens junctions, gap junctions, and desmosomal junctions.[@bib2]

The apical-most TJs act as fences that maintain polarity by separating apical and basolateral membrane components of the epithelium, and form the major paracellular barrier.[@bib3] Adherens junctions, located immediately below TJs, comprise transmembrane cadherins and cytoplasmically attached α- and β-catenins that connect to cytoskeletal actin filaments.[@bib4] Desmosomal junctions, comprising membrane-anchored desmoglein (DSG) and desmocollin (DSC), form spot-welds that confer stability and strength to cell junctions. Four DSG (DSG1--4) and 3 DSC (DSC1--3) isoforms are expressed in human beings in a tissue-specific manner.[@bib5] Only DSG2 and DSC2 are expressed in normal human intestinal epithelium.[@bib6] The N-termini of DSG and DSC are located in the intercellular space, and form homotypic and heterotypic interactions with desmosomal cadherins of adjacent cells.[@bib7] The plaque proteins plakoglobin, plakophilin, and desmoplakin connect the C-termini of DSG and DSC to intermediate filaments (IFs).[@bib8] Many disease states are marked by relocalization of junctional proteins, increased paracellular permeability, loss of cell--cell adhesion, and, in extreme cases, the gross exfoliation of cells.[@bib9]

Enteropathogenic *Escherichia coli* (EPEC) is a leading cause of juvenile diarrheal disease mortality.[@bib10] EPEC belongs to the attaching and effacing (A/E) family of pathogens that intimately attach to epithelial cells and efface brush-border microvilli.[@bib11] EPEC elaborates a type III secretion system (T3SS) that translocates effector proteins into host cells and thereby modulates host cell signaling. Notably, effector protein-dependent barrier perturbation is thought to contribute to EPEC-induced diarrhea.[@bib12] The EPEC effectors EspF, EspG1/G2, Map, and NleA disrupt TJs and compromise epithelial barrier function.[@bib13], [@bib14], [@bib15], [@bib16], [@bib17] EPEC outer-membrane proteins disrupt adherens junctions by inducing the dissociation of cadherin/β-catenin complexes.[@bib18]

Early electron microscopy studies on small intestinal biopsy samples from EPEC-infected children showed a separation of the lateral intercellular junctions of epithelial cells.[@bib19] We observed similar widening of paracellular junctions in EPEC-infected IECs, specifically in regions below the TJs. To test the hypothesis that the loss of desmosomes contributed to these changes, we evaluated desmosomal protein abundance in infected IECs. EPEC infection induced a marked decrease in DSG2, the only IEC desmoglein isoform. The aim of this study, therefore, was to investigate the mechanisms and impact of EPEC-induced DSG2 down-regulation in vitro and in vivo. Our studies show a novel role for the effector protein EspH, and for Rho guanosine triphosphatase (GTPase) signaling, in modulating epithelial monolayer integrity, barrier function, and bacterial colonization.

Materials and Methods {#sec1}
=====================

Cell Lines {#sec1.1}
----------

The human IEC line C2~BBe~, a brush-border--expressing Caco-2 subclone,[@bib20] was used and cultured as reported previously.[@bib21]

Bacterial Strains and Generation of Mutants {#sec1.2}
-------------------------------------------

The EPEC O127:H6 strain E2348/69 and its isogenic derivatives, and the commensal *E coli* strain HS4, were used ([Table 1](#tbl1){ref-type="table"}). E2348/69 *espH* was disrupted via homologous recombination.[@bib22] A 202-bp *espH* internal fragment (base pairs 181--382) was cloned into the suicide vector pJP5603,[@bib23] and the resulting construct, pSE864, was introduced into E2348/69 via conjugation. Transconjugants were confirmed for *espH* disruption by polymerase chain reaction and Southern blot, and 1 representative *espH* mutant, SE874, was used. For complementation studies, full-length *espH* was amplified and cloned into pTrcHis2-TOPO TA (Thermo Fisher Scientific, Waltham, MA) to generate pJLR1, and transformed into SE874 to generate SE874/C. *espH* also was cloned in-frame with the 6XHis tag sequence of pTrcHis2-TOPO TA (pJLR2). Alanine scans have been empirically found to be a particularly effective method for assessing the functional importance of residues within a protein.[@bib24] To identify EspH residues involved in RhoA inhibition, a panel of 29 *espH* alanine-scan mutants were engineered by sequentially replacing 5--amino acid stretches of EspH (excluding the N-terminal 25 amino acids containing the secretion signal) with alanine residues. To facilitate cloning of these mutants, an *Xho*I restriction site was introduced into pJLR2 via a 703G→A silent substitution to generate pJLR4. Dispase assay screens (described later) identified EspH mutants M14 and M16, corresponding to alterations of amino acids 88--92 and 98--102, respectively, as candidates for further study. To verify that M14 and M16 retained wild-type levels of EspH secretion, culture supernatants of wild-type (WT) EPEC and mutant strains grown in serum-free Dulbecco\'s modified Eagle medium (DMEM) were immunoblotted as described later.Table 1Bacterial Strains, Plasmids, and PrimersStrainGenotype/descriptionReferenceHS4Nonpathogenic *E coli*[@bib63]EPEC*E coli* O127:H6 strain E2348/69, Nal^R^ ; parent strain for all mutants/complements below[@bib64], [@bib65]Δ*espA*Nonpolar insertion in *espA*; Nal^R^, Kan^R^[@bib66]SE874Insertional disruption of *espH*; Kan^R^, Nal^R^This studySE874/CSE874 complemented with pJLR1This studyPlasmidspJP5603Suicide vector[@bib23]pSE864pJP5603 with 202-bp insert corresponding to *espH* bp181-382; used for generating SE874This studySE874 complementation plasmids: vector: pTrcHis2TOPO-TApJLR1*espH* amplified with primers EspH1 and EspH2 Expresses WT EspHThis studypJLR2*espH* amplified with primers EspH1 and EspH3\
Expresses WT EspH with C-terminal 6xHis tagThis studypJLR4*espH* with silent mutation at (703G\>A) to introduce *Xho*I restriction site\
Expresses WT EspH with C-terminal 6xHis tagThis studyM14Alanine-scan mutant\
Expresses EspH 88AAAAA92, His-taggedThis studyM16Alanine-scan mutant\
Expresses EspH 98AAAAA102, His-taggedThis studyPrimersEspH15'-ATGTCGTCATCATTATCAG-3'This studyEspH25'-TTAAACTGTCACACCTGAT-3'This studyEspH35'-AACTGTCACACCTGAT-3'This study

Growth of Bacteria and Infection of IECs {#sec1.3}
----------------------------------------

C2~BBe~ culture medium was changed to serum-free DMEM 16 hours before infection. For infections, overnight bacterial cultures (in Luria--Bertani broth with appropriate antibiotics for plasmid selection) were subcultured at 1:20 dilution in serum-free DMEM and grown to midlogarithmic phase (OD~600nm~, 0.4) at 37°C. Bacteria were added to the apical surface of IECs corresponding to an initial multiplicity of infection of 100, and infections were allowed to proceed for 3 hours unless otherwise indicated. For studies involving Rho activation or actin polymerization, IECs were pretreated with 300 ng/mL cytotoxic necrotizing factor 1--based Rho activator CN03 (Cytoskeleton, Inc, Denver, CO) or 1 μmol/L jasplakinolide (Thermo Fisher Scientific), for 1 hour before infection. For inhibitor studies, IECs were pretreated with 50 μmol/L pan-caspase inhibitor z-DEVD-fmk, 52 nmol/L calpain inhibitor I, 10 μmol/L proteasomal inhibitor MG132, or 250 nmol/L lysosomal inhibitor bafilomycin A1 (Sigma-Aldrich, St. Louis, MO) for 2 hours before infection, and inhibitor levels were maintained through the course of infection.

Protein Extraction {#sec1.4}
------------------

Mock-treated and infected monolayers were washed with ice-cold, sterile phosphate-buffered saline (PBS) with calcium and magnesium (PBS-CM), scraped, harvested via centrifugation, resuspended in urea buffer (7 mol/L urea, 2 mol/L thiourea, 100 mmol/L 1,4-dithiothreitol, and 4% 3-\[(3-Cholamidopropyl)dimethylammonio\]-1-propanesulfonate hydrate), and lysed via sonication or by silica bead-beating (Bead Ruptor; Omni International, NW Kennesaw, GA).

Immunoblot Analyses {#sec1.5}
-------------------

Protein extracts (50--100 μg) were separated by 7% sodium dodecyl sulfate--polyacrylamide gel electrophoresis, and transferred to 0.2-μm nitrocellulose membranes, which were blocked with 5% nonfat milk in Tris-buffered saline containing Tween 20 and incubated with anti-DSG2, anti-DSC2, or anti-actin antisera (Abcam, Cambridge, MA; Sigma-Aldrich) following product recommendations. Horseradish-peroxidase--conjugated goat anti-rabbit and anti-mouse antisera (Sigma-Aldrich) were used as secondary antisera. Membranes were developed with SuperSignal West Femto Chemiluminescent Substrate (Thermo Fisher Scientific).

Co-immunoprecipitation Studies {#sec1.6}
------------------------------

C2~BBe~ cells were grown to 60% confluency and transfected with pEnter expression plasmid harboring C-terminal Flag-tagged p115-Rho guanine nucleotide exchange factor (GEF) (Vigene, Rockville, MD). Transfection was facilitated using jetPRIME transfection reagent (Polyplus Transfection, Illkirch, France) following the manufacturer's protocol. Two days after transfection, C2~BBe~ cells were infected with EPEC strains at a multiplicity of infection of 100 for 3 hours. Samples were washed with ice-cold PBS, scraped, and harvested via centrifugation. Proteins were extracted in immunoprecipitation lysis buffer containing 50 mmol/L TrisCl (pH 7.4), 150 mmol/L NaCl, 1 mmol/L EDTA, 1% Nonidet P-40, 0.25% sodium deoxycholate, and 1 × Halt protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific). Immunoprecipitation was performed on 5-mg protein extracts using Surebeads Protein A Magnetic beads (Bio-Rad Laboratories, Hercules, CA) bound with anti-Flag M2 antibody (Sigma-Aldrich). The presence of Flag-tagged p115-RhoGEF and His-tagged EspH in the immunoprecipitated samples was determined via Western blot analysis using p115-RhoGEF antibody (Abcam) and anti-6xHis-tag antibody (Cell Signaling, Danvers, MA). To assess EspH secretion, 30-mL cultures of EPEC strains inoculated in serum-free DMEM and normalized to midlogarithmic phase (OD~600nm~, 0.4) were grown for 3 hours at 37°C. Cultures were centrifuged at 400*g* for 10 minutes. Bacterial supernatants were filter-sterilized and concentrated using Amicon 3-kilodalton cut-off filters (MilliporeSigma, Burlington, MA). EspH secretion was assessed via immunoblot analysis using anti-6xHis-tag antibody.

Dispase Assay {#sec1.7}
-------------

Cell adhesion strength was assessed using a modified dispase assay.[@bib25] Briefly, mock-treated and infected IEC monolayers were washed with Hank's balanced salt solution with CM, and incubated with dispase (20 mg/mL in Hank's balanced salt solution with CM) at 37°C and 5% CO~2~ for 30 minutes. Detached monolayers were agitated mechanically for 5 minutes, and monolayer disruption was scored qualitatively (none, partial, or full).

RhoA Activity Assays {#sec1.8}
--------------------

The low RhoA activity signal under standard infection conditions impeded detection of further EPEC/EspH-mediated inhibition. To overcome this, baseline RhoA activity was boosted by pretreating serum-starved, confluent IECs with 5 μmol/L lysophosphatidic acid for 1 hour before infection. RhoA activity in cell extracts were measured using a RhoA G-LISA Activation Assay Kit (Cytoskeleton, Inc).

Transepithelial Electrical Resistance Measurements {#sec1.9}
--------------------------------------------------

Polarized IECs grown on 0.33-cm^2^ collagen-coated Corning Transwells (Thermo Fisher Scientific) were apically infected with EPEC strains (WT, SE874, and SE874/C) cultured in DMEM as described earlier. Measurements were made every hour for 6 hours after infection using an epithelial volt-Ohm voltmeter (World Precision Instruments, Sarasota, FL), and transepithelial electrical resistance (TER) was calculated by applying Ohm's Law.

Mouse Model of EPEC Infection {#sec1.10}
-----------------------------

All procedures were approved by the University of Arizona Institutional Animal Care and Use Committee. Six-week-old C57BL/6J male mice (Jackson Laboratory, Bar Harbor, ME) were infected as reported previously.[@bib26] Briefly, streptomycin-treated mice (5 g/L streptomycin in drinking water ad libitum for 24 hours, followed by sterile water for 24 hours), were gavaged with 150 μL sterile PBS (control, uninfected), or 2 × 10^8^ bacteria suspended in 150 μL sterile PBS, and monitored for up to 4 days after infection.

Attachment Assays {#sec1.11}
-----------------

To assess EPEC attachment to the intestinal mucosa, WT- or SE874-infected C57BL/6J mice were euthanized on days 3 and 4 after infection (4 animals per condition). Segments of the cecum and proximal colon were isolated, cleaned, weighed, homogenized, serially diluted in PBS, and bacteria were enumerated on MacConkey agar containing 100 μg/mL nalidixic acid.

Fecal Shedding of EPEC {#sec1.12}
----------------------

Mouse stool samples were collected daily for 4 days after infection, and weighed, homogenized in PBS, serially diluted, and bacteria were enumerated on MacConkey agar containing 100 μg/mL nalidixic acid. No colonies were recovered from the stool of uninfected animals, consistent with media selectivity for EPEC.

Immunofluorescence Microscopy {#sec1.13}
-----------------------------

Cultured monolayers were grown on poly-L-lysine--coated coverslips. For mouse intestinal tissues, samples were frozen in OCT embedding medium (Tissue-Tek; Sakura Finetek, Torrance, CA) and stored at -80°C. Cultured monolayers and OCT-mounted tissue samples cut at 4-micron thickness were fixed in a 1:1 mixture of methanol and acetone for 20 minutes at -20°C, air-dried, rehydrated in PBS for 5 minutes, permeabilized with 0.2% Triton X-100 (Sigma-Aldrich, St. Louis, MO) in PBS for 15 minutes, and blocked with 5% IgG-free bovine serum albumin (BSA) in PBS for 1 hour. Primary antibodies used for cultured cells were 1:40 dilution of mouse anti-DSG2 and 1:1000 dilution of rabbit anti--lysosomal-associated membrane protein 1 (Abcam); mouse tissues were probed with 1:40 dilution of rabbit anti-DSG2 (Sigma Aldrich). Samples were incubated with primary antisera overnight at 4°C, and then washed 3 times with 1% IgG-free BSA in PBS. Secondary antibodies (Alexa 488--conjugated goat anti-mouse IgG, Alexa Fluor 555--conjugated anti-rabbit IgG, or Alexa 488 goat anti-rabbit IgG antisera; Thermo Fisher Scientific) were added at 8 μg/mL in 5% IgG-free BSA for 1 hour. Samples were washed with PBS, stained with 4,6-diamidino-2-phenylindole, and mounted in ProLong Diamond Antifade reagent (Thermo Fisher Scientific). Images were captured on a DeltaVision Elite Deconvolution Microscope (GE Healthcare, Pittsburgh, PA) using an Olympus 60×/1.42 objective with 1.59× auxiliary magnification or an Olympus 100×/1.4 objective (immersion oil refractive index, n = 1.516) (Sigma-Aldrich).

Transmission Electron Microscopy {#sec1.14}
--------------------------------

Polarized IECs grown on 0.33-cm^2^ collagen-coated Transwells (Thermo Fisher Scientific) were apically infected with EPEC strains cultured in DMEM. IECs and tissue samples were fixed in Karnovsky's Fixative (Electron Microscopy Sciences, Hatfield, PA) overnight at 4°C, neutralized with 125 mmol/L glycine in PBS, postfixed in 1% osmium tetroxide, and sequentially dehydrated with 15%, 30%, 50%, 70%, 90%, and 100% ethanol. Samples then were infiltrated with Spurr's Resin (Electron Microscopy Sciences). Ultrathin sections were contrasted with 2% uranyl acetate, followed by Reynold's lead citrate, and visualized with an FEI Tecnai Spirit transmission electron microscope (FEI, Hillsboro, OR).

Statistical Analyses {#sec1.15}
--------------------

Significant changes for all pairwise sample comparisons in experiments involving quantitation were assessed by analysis of variance with Bonferroni post hoc test.

All authors had access to the study data and have reviewed and approved the final manuscript.

Results {#sec2}
=======

EspH Mediates Desmoglein-2 Loss in EPEC-Infected Epithelial Cells {#sec2.1}
-----------------------------------------------------------------

To explore the molecular basis for the cell--cell separation previously seen in EPEC-infected patient tissues,[@bib19] infected IEC extracts were immunoblotted for the transmembrane, spot-weld protein DSG2, the only desmoglein isoform present in the intestine. We observed substantial DSG2 loss at 3 hours after EPEC infection, but not in mock-treated cells ([Figure 1](#fig1){ref-type="fig"}*A*). Immunofluorescence of mock-treated cells, and cells infected with WT EPEC for up to 1 hour, showed the typical junctional localization of DSG2 noted previously.[@bib27] At 2 hours after infection, there was evidence of DSG2 displacement from the cell junctions, and internalization of this protein into the cytosol ([Figure 1](#fig1){ref-type="fig"}*B*); by 3 hours, DSG2 was substantially depleted from infected cells, mirroring the immunoblot results.Figure 1**EPEC induces desmoglein-2 loss.** C2~BBe~ monolayers were mock-treated, or infected with EPEC at a multiplicity of infection of 100 for 0.5, 1, 2, and 3 hours. (*A*) Whole-cell extracts of mock-treated or EPEC-infected C2~BBe~ were immunoblotted for DSG2 and actin loading control. Scatter plot shows the densitometry analysis of the abundance of DSG2/actin of each sample compared with mock 0.5 h (3 independent experiments). The median values are indicated by *horizontal lines*. *P* values for the DSG2/actin ratio of EPEC 3 hours vs mock 3 hours were computed using analysis of variance with the Bonferroni post hoc test. (*B*) Immunofluorescence staining of DSG2 (magenta) in mock-treated or EPEC-infected C2~BBe~ imaged with the DeltaVision Elite Deconvolution Microscope equipped with an Olympus 100×/1.40 oil objective and using immersion oil (n = 1.516). 4,6-Diamidino-2-phenylindole (blue) was used to stain DNA. *Scale bar*: 10 μm. Blots and images are representative of 3 independent experiments. For immunofluorescence staining, at least 6 fields per sample were captured in each experiment.

In contrast to WT EPEC, an isogenic T3SS-deficient strain (Δ*espA*) failed to deplete DSG2 ([Figure 2](#fig2){ref-type="fig"}*A*), suggesting a role for 1 or more secreted effectors in the process. To identify the effector proteins involved, we assessed DSG2 abundance in IECs infected with isogenic EPEC mutants lacking specific effector molecules. EPEC Δ*map*, Δ*tir*, Δ*espG*, Δ*espF*, and Δ*espZ* caused DSG2 loss similar to the WT strain, ruling out a role for the corresponding effectors in DSG2 down-regulation (not shown). A strain lacking EspH (SE874), however, failed to deplete DSG2, and this defect was reversed by *espH* complementation (SE874/C) ([Figure 2](#fig2){ref-type="fig"}*B*). The major heterotypic partner of DSG2, DSC2, also was depleted in EPEC-infected IECs in an EspH-dependent manner ([Figure 2](#fig2){ref-type="fig"}*C*). Although DSC2 is the primary isoform expressed in the normal intestine, other desmocollin isoforms have been observed in disease states.[@bib28] Therefore, all further studies focus on DSG2, with DSC2 included as a validation control where appropriate. In contrast to WT-infected cells, junctional DSG2 staining was maintained in mock-treated and SE874*-*infected cells ([Figure 2](#fig2){ref-type="fig"}*D*); complementation (SE874/C) restored the ability of the *espH* mutant to displace DSG2 from the junctions and cause its depletion.Figure 2**EPEC EspH induces desmoglein-2 redistribution and loss.** (*A--C*) Whole-cell extracts of C2~BBe~ mock-treated, or infected with EPEC, (*A*) the T3SS mutant Δ*espA*, or (*B* and *C*) *espH* mutant SE874 and corresponding complement SE874/C were immunoblotted for (*A* and *B*) DSG2 or (*C*) DSC2, and (*A--C*) actin loading control. Blots shown are representative of 4 independent experiments. Scatter plot shows densitometry analysis of the abundance of DSG2 or DSC2 relative to actin, respectively, for each sample compared with mock. *Horizontal lines* represent median values. \**P* = .0001 for the DSG2/actin ratio of specific sample comparisons calculated using analysis of variance with the Bonferroni post hoc test. (*D*) Immunofluorescence staining of DSG2 (magenta) in mock-, EPEC-, SE874-, and SE874/C-infected C2~BBe~ cells imaged using the DeltaVision Elite Deconvolution Microscope equipped with an Olympus 100×/1.40 oil objective and immersion oil (n = 1.516). 4,6-Diamidino-2-phenylindole (blue) was used to stain DNA. *Scale bar*: 6 μm. Images are representative of at least 3 independent experiments. All immunofluorescence images are representative of \>6 fields per sample captured for each independent experiment.

Previous studies have shown the perturbation of TJs in EPEC-infected intestinal epithelial cells, notably the displacement of occludin and zonula occludens 1 from the TJ regions.[@bib13], [@bib14], [@bib15], [@bib16], [@bib17] In some images of intestinal epithelia from biopsy specimens of EPEC-infected children, however, TJs appeared intact in regions where basolateral unzipping was evident. We therefore used immunofluorescence to assess the temporal relationship between TJ and desmosomal disruptions in EPEC-infected epithelial cells. At 3 hours after infection, occludin staining was restricted primarily to the junctions of infected epithelial cells compared with mock-treated cells ([Figure 3](#fig3){ref-type="fig"}*A*). In contrast, DSG2 is substantially internalized and lost by this time point, suggesting that desmosomal alterations precede TJ disruption.Figure 3**Desmoglein-2 perturbation precedes tight junction disruption in EPEC-infected cells.** (*A* and *B*) C2~BBe~ cells were infected with EPEC at a multiplicity of infection of 100 for 3 hours. (*A*) Cells were stained for desmoglein-2 (magenta), tight junction protein occludin (green), and 4,6-diamidino-2-phenylindole (DAPI; blue). All images were imaged using the DeltaVision Elite Deconvolution Microscope equipped with an Olympus 60×/1.42 oil objective and 1.59 auxiliary magnification and using immersion oil (n = 1.516). *Scale bar*: 6 μm. (*B*) EPEC EspH perturbs desmosomes. Transmission electron micrographs of mock-treated (*left-most panel*) or infected IECs showing desmosomes (*magenta arrows*) and areas of unzipping and separation of lateral membranes (*blue arrows*). *Green arrowheads* point to TJs. *Scale bar*: 500 nm. All images are representative of at \>6 fields captured per sample from 3 independent experiments.

Because EPEC depletes DSG2 and DSC2, we assessed desmosomal integrity in infected cells via transmission electron microscopy. Densely staining desmosomes tracked along the lateral walls of mock-treated IECs, as well as cells infected with SE874 ([Figure 3](#fig3){ref-type="fig"}*B*). In contrast, WT EPEC- or SE874/C-infected cells had reduced desmosomal staining, areas of unzipping, and junctional separation. Notably, despite separation of the lateral membranes, TJs appeared intact, further indicating that desmosomal perturbations likely precede EPEC-induced TJ disruption. Collectively, these data suggest that EspH induces DSG2 displacement and loss from cell junctions, leading to desmosomal perturbations and loss of cell--cell contacts.

EPEC EspH Compromises Cell--Cell Adhesion and Epithelial Barrier Function {#sec2.2}
-------------------------------------------------------------------------

Because desmosomes are critical scaffolds between the lateral membranes of epithelial cells, we assessed the impact of EPEC-induced DSG2 loss on cell junction strength. Dispase-treated mock-infected and commensal *E coli*--infected cells, as well as Δ*espA*-infected and SE874-infected cells, were displaced from the plastic substratum, but remained as intact sheets ([Figure 4](#fig4){ref-type="fig"}*A*). In contrast, and consistent with EspH-dependent DSG2 loss, EPEC-infected and SE874/C-infected monolayers disintegrated into small fragments.Figure 4**EspH weakens junctional integrity and disrupts barrier function of infected host epithelial monolayers.** (*A*) Images showing C2~BBe~ monolayer integrity after mock treatment, or infection with commensal *E coli* HS4, EPEC WT, Δ*espA*, SE874, and SE874/C, respectively, followed by dispase treatment and agitation. Images are representative of 3 independent experiments. (*B*) TER assays to measure barrier integrity in mock-, EPEC-, SE874*-*, or SE874/C*-*infected cells. Cells were infected at an initial multiplicity of infection of 100. \**P* = .0001 for EPEC or SE874/C compared with SE874 for time points indicated. Data are representative of 3 independent TER assays with at least 3 sample replicates per condition.

To determine if DSG2 loss impacted barrier function, we monitored infection-mediated TER changes in polarized C2~BBe~ monolayers. WT EPEC induced a progressive decrease in TER relative to mock-treated epithelial cells ([Figure 4](#fig4){ref-type="fig"}*B*). Lack of EspH (SE874) markedly impaired the ability to decrease TER, while complementation (SE874/C) restored the phenotype. Collectively, this suggests that EspH-induced DSG2 loss and desmosomal perturbations compromise epithelial monolayer integrity, leading to loss of epithelial barrier function.

EspH-Dependent DSG2 Redistribution and Loss Correlates With RhoA Inhibition {#sec2.3}
---------------------------------------------------------------------------

EspH (∼168 amino acids) is unique to A/E pathogens, and does not show significant sequence similarity to other proteins. EspH interaction with Rho GEFs Dbl homology-plecstrin homology domains inhibits Rho GTPase activation, and perturbs the actin cytoskeletion.[@bib29] However, the specific EspH residues involved in these processes remain undefined. To identify EspH domains involved in Rho GTPase inhibition, and in DSG2 relocalization, we generated a panel of alanine-scan mutants. The parent plasmid (encoding WT EspH) and mutant derivatives were used to complement the *espH-*deficient SE874 strain. Transfected C2~BBe~ cells expressing p115-RhoGEF were infected with this panel of strains, and the extracts were assessed for EspH-p115 RhoGEF interactions. Co-immunoprecipitation studies confirmed interaction of EspH with p115-RhoGEF ([Figure 5](#fig5){ref-type="fig"}*A*); in contrast, 2 alanine-scan mutants, M14 and M16, with replacements of amino acids 88--92 and 98--102, respectively, failed to pull down p115-RhoGEF. The lesions in M14 and M16 did not compromise EspH secretion via the T3SS ([Figure 5](#fig5){ref-type="fig"}*A*).Figure 5**EspH inhibition of RhoA correlates with DSG2 loss and weakening of cell--cell interactions in EPEC-infected monolayers.** (*A*) Transfected C2~BBe~ cells expressing Flag-tagged p115-RhoGEF were infected with EPEC, SE874, or SE874 complemented with pJLR4 (WT, His-tagged) or alanine scan mutants M14 (88AAAAA92) or M16 (98AAAAA102). Flag-tagged p115-RhoGEF were immunoprecipitated from whole-cell extracts using anti-Flag antibody. Immunoprecipitated samples were blotted for p115-RhoGEF and His-tagged EspH. Blots shown are representative of 3 independent experiments. Densitometry analysis shows abundance of co-immunoprecipitated His-tagged EspH relative to p115-RhoGEF. *Horizontal line* represents median. Corresponding bacterial supernatants were concentrated and blotted for His-tagged EspH. Image is of a single gel with irrelevant lanes removed. *P* values for complemented strains, relative to SE874, are .0001 (pJLR4), .222 (M14), and 1.000 (M16), respectively. (*B*) RhoA activity in lysophosphatidic acid--treated C2~BBe~ cells infected with EPEC, SE874, SE874/C, or SE874 complemented with pJLR4 (his-tagged EspH), M14, or M16 (alanine-scan mutants). Images are representative of 2 independent RhoA activity assays with 3 sample replicates per condition. *P* values are .0192 (mock vs EPEC) and .9721 (mock vs SE874); for the complemented strains, relative to SE874, *P* values are .0145 (pJLR1), .0364 (pJLR4), .0303 (M14), and .1797 (M16), respectively. (*C*) Extracts of mock-treated C2~BBe~ cells, or C2~BBe~ infected with the same strains as in panel *B* immunoblotted for DSG2 and DSC2 (*upper two panels*), and actin (loading control, *lower panel*). Scatter plot shows densitometry analysis of the abundance of DSG2/actin or DSC2/actin for each sample compared with mock. *Horizontal line* represents median. For DSG2/actin abundance ratios, *P* = .0001 for mock vs EPEC and mock vs SE874. *P* for the complemented strains, relative to SE874, are .0001 (pJLR1), .0002 (pJLR4), .4506 (M14), and .7078 (M16), respectively. For DSC2/actin abundance ratios, *P* = .0001 for mock vs EPEC and mock vs SE874. *P* values for the complemented strains, relative to SE874, are .0001 (pJLR1), .0001 (pJLR4), .9030 (M14), and .3527 (M16), respectively. (*D*) Dispase assays using the same strains described in panel *B*, and visualization of cell junctional integrity after mechanical agitation. All images for immunoblot and dispase assay are representative of 3 independent experiments. All infections were performed at an initial multiplicity of infection of 100 for 3 hours. COIP, co-immunoprecipitation.

The corresponding mutants were assessed for their ability to inhibit Rho GTPase activty. WT EPEC, but not SE874, inhibited RhoA activity in IECs ([Figure 5](#fig5){ref-type="fig"}*B*). Complementation of SE874 (SE874/C \[=SE874/pJLR1\] or SE874/pJLR4 \[His-tagged EspH\]) restored the ability to inhibit RhoA. In contrast, the RhoGEF interaction-defective mutants M14 and M16 failed to complement SE874 for RhoA inhibition ([Figure 5](#fig5){ref-type="fig"}*B*). Unlike WT *espH-*complemented SE874, M14- and M16-complemented SE874 also failed to induce the loss of DSG2, or its major heterotypic partner DSC2 ([Figure 5](#fig5){ref-type="fig"}*C*). Finally, M14 and M16 failed to complement SE874 for monolayer fragmentation, as assessed in the dispase assay ([Figure 5](#fig5){ref-type="fig"}*D*). Host-cell adherence of all strains was comparable with WT EPEC (not shown). These data support a model whereby EPEC EspH-mediated Rho GTPase inhibition promotes internalization and loss of the desmosomal proteins DSG2 and DSC2, causes the separation of the lateral membranes of adjacent cells, and compromises cell--cell adhesion and barrier function.

Mechanism of EspH-Mediated DSG2 Loss in Infected Cells {#sec2.4}
------------------------------------------------------

EspH competitively binds to RhoGEFs and inhibits Rho GTPase activation.[@bib29] Although Rho GTPases were implicated in desmosomal protein anchoring to IFs in keratinocytes,[@bib30] their contributions to desmosomal integrity in IECs has not been investigated. We therefore explored if Rho activator II CN03 could rescue RhoA activation and restore DSG2 levels downstream of the EspH-RhoGEF block. CN03 is based on the catalytic domain of cytotoxic necrotizing factor 1, which irreversibly deamidates Gln63 of RhoA and locks it in the active confirmation.[@bib31], [@bib32] Although EPEC infection depleted DSG2 in infected cells, CN03 treatment restored DSG2 abundance ([Figure 6](#fig6){ref-type="fig"}*A*) and its localization ([Figure 6](#fig6){ref-type="fig"}*B*). CN03 alone did not have discernable impacts on DSG2 abundance or localization in mock-treated cells ([Figure 6](#fig6){ref-type="fig"}*A* and *B*). This further supports the contention that EspH induces DSG2 loss by inhibiting Rho GTPases.Figure 6**Rho GTPase activation, as well as actin stabilization, rescues EPEC-infected cells from DSG2 loss.** (*A* and *B*) C2~BBe~ cells were pretreated with H~2~O vehicle control (*A*, lanes 1 and 2; *B*, upper row), or 300 ng/mL CN03 (*A*, lanes 3 and 4; *B*, bottom row) for 1 hour before, and continuing through, EPEC infection. Total proteins were extracted and analyzed for the abundance of (*A*) DSG2, or infected cells fixed and immunostained for (*B*) DSG2 (magenta) and 4,6-diamidino-2-phenylindole (DAPI; blue). (*A*) Scatter plot shows densitometry analysis of the abundance of DSG2/actin of EPEC-infected sample compared with corresponding mock. *Horizontal line* represents median. Immunoblots are representative of 4 independent experiments. *P* = .0001 (mock + vehicle vs EPEC + vehicle), .6657 (mock + CN03 vs EPEC + CN03), and .0001 (EPEC + vehicle vs EPEC + CN03). (*C*) C2~BBe~ cells were pretreated with dimethyl sulfoxide vehicle control or 1 μmol/L jasplakinolide for 1 hour before, and continuing through, infection (mock, WT EPEC, SE874, or SE874/C), and fixed and immunostained for DSG2 (magenta), cytokeratin 8/18 \[green\], and DAPI \[blue\]. Infections were performed at an initial multiplicity of infection of 100 for 3 hours. *Arrows* mark IF retraction from cell membranes. All immunofluorescence images were captured using the DeltaVision Elite Deconvolution Microscope equipped with an Olympus 60×/1.42 oil objective and using immersion oil (n = 1.516), and are representative of \>6 fields per sample from 3 independent experiments. *Scale bar*: 11 μm.

To our knowledge, there is no known pathway linking Rho GTPases to DSG2 stabilization at cell junctions. Because Rho GTPase activation can stimulate actin polymerization, we considered a role for cytoskeletal modulation in EPEC-induced DSG2 down-regulation. The actin cytoskeleton plays a role in maintaining keratin IFs, and facilitates IF anchorage to desmosomes via the cytolinker desmoplakin.[@bib33], [@bib34] Keratin IF precursors nucleate at desmosomes, and then translocate continuously toward the nucleus until they integrate end-on into the peripheral IF network.[@bib35] Importantly, this inward-directed transport of keratin IF precursors depends on actin retrograde flow.[@bib36] We therefore hypothesized that EspH-mediated Rho inactivation and consequent actin destabilization impairs the normal actin-dependent transport of keratin IFs, ultimately disrupting DSG2 and desmosome -anchoring at the junctions. To test this hypothesis, we infected IECs with EPEC strains and visualized IFs (via cytokeratin 8/18 staining) and DSG2. Consistent with our hypothesis, keratin staining was disrupted, or absent, in IECs infected with WT EPEC and SE874/C ([Figure 6](#fig6){ref-type="fig"}*C*); in several cells, the staining was suggestive of IF collapse away from the cell periphery, and toward the nucleus. Keratin staining remained intact, and comparable with mock-treated cells, in SE874-infected IECs ([Figure 6](#fig6){ref-type="fig"}*C*). This suggests that EspH impedes the inward-directed transport of new and maturing keratin IFs. Consistent with a role for cytoskeletal perturbation in this process, the actin-stabilizing drug jasplakinolide preserved IF integrity and DSG2 membrane localization in EPEC- and SE874/C-infected cells ([Figure 6](#fig6){ref-type="fig"}*C*). In the absence of infection, jasplakinolide did not impact DSG2 localization or abundance. Together, these data suggest that EspH-dependent Rho GTPase inactivation leads to actin depolymerization; this, in turn, perturbs IF stability and, ultimately, leads to destabilization of desmosomes and DSG2 down-regulation.

DSG2 Is Internalized and Degraded in the Lysosomes of EPEC-Infected Cells {#sec2.5}
-------------------------------------------------------------------------

Destabilized desmosomes can split into half-desmosomes and be internalized; in keratinocytes, desmogleins are degraded via the lysosomal or proteasomal pathways.[@bib37] To assess DSG2 fate in EPEC-infected IECs, we determined the effects of the lysosomal inhibitor bafilomycin A1 and the proteasomal inhibitor MG132. Bafilomycin A1, but not the vehicle dimethyl sulfoxide, prevented EPEC-induced DSG2 loss ([Figure 7](#fig7){ref-type="fig"}*A*). MG132 had no apparent impact on infection-induced DSG2 displacement from the cell junctions to the cytosol ([Figure 7](#fig7){ref-type="fig"}*B*), but partially protected against DSG2 loss ([Figure 7](#fig7){ref-type="fig"}*A*). In contrast, lysosomal inhibition protected against EPEC-induced DSG2 loss ([Figure 7](#fig7){ref-type="fig"}*A*); moreover, DSG2 was internalized, and co-localized with lysosomal-associated membrane protein 1 in bafilomycin-treated, EPEC-infected IECs ([Figure 7](#fig7){ref-type="fig"}*B*). Taken together, these results suggest that EPEC EspH promotes junctional instability of DSG2, leading to its internalization and subsequent degradation primarily within lysosomes.Figure 7**DSG2 is degraded in the lysosomes of EPEC-infected cells.** C2~BBe~ cells were pretreated with 250 nmol/L lysosomal inhibitor bafilomycin A1, 10 μmol/L proteasomal inhibitor MG132, or dimethyl sulfoxide vehicle control for 2 hours before infection with EPEC at a multiplicity of infection of 100 for 3 hours. Inhibitor concentrations were maintained throughout the course of infection. (*A*) Total protein extracts immunoblotted for DSG2 (or actin; loading control). Scatter plot shows densitometry analysis of the abundance of DSG2/actin of EPEC-infected sample compared with corresponding mock. *Horizontal line* represents median. Immunoblots are representative of 3 independent experiments. *P* = .0001 for EPEC + MG132 and EPEC + bafilomycin A1 compared with EPEC + vehicle, respectively. (*B*) Mock-treated and infected cells were fixed and immunostained for DSG2 (magenta), lysosomal-associated membrane protein 1 (LAMP1; green), and 4,6-diamidino-2-phenylindole (blue). *Arrows* point to co-localized DSG2 and LAMP1. All images were captured using the DeltaVision Elite Deconvolution Microscope equipped with an Olympus 100×/1.40 oil objective and using immersion oil (n = 1.516), and are representative of \>6 fields per sample from 3 independent experiments.

We explored 2 alternate pathways for direct DSG2 cleavage in EPEC-infected cells. EspH activates caspase-3, a cysteine--aspartic acid protease involved in programmed cell death.[@bib38] EPEC also activates calcium-dependent nonlysosomal enzymes (calpains), although EspH has not been implicated in this pathway.[@bib39] Because DSG2 is a known target of both caspases and calpains,[@bib40] we assessed the effects of calpain inhibitor I and the pan-caspase inhibitor z-DEVD-fmk, respectively, on EPEC-induced DSG2 loss. Neither inhibitor impacted infection-induced DSG2 loss, indicating that caspases and calpains are not involved in this process (data not shown).

EspH Contributes to EPEC-Induced DSG2 Relocalization, and to Intestinal Colonization, in a Mouse Model of Infection {#sec2.6}
-------------------------------------------------------------------------------------------------------------------

Finally, we assessed EPEC-induced DSG2 down-regulation and desmosomal perturbation in vivo using a mouse colonization model.[@bib26], [@bib41] WT EPEC robustly colonized the mouse cecum and colon on days 3 and 4 after infection ([Figure 8](#fig8){ref-type="fig"}*A*). Although SE874 colonization of the cecum and colon were comparable with WT EPEC on day 3 after infection, its levels decreased at both sites by day 4 after infection ([Figure 8](#fig8){ref-type="fig"}*A*), suggesting a role for EspH in EPEC persistence in the mouse intestine. Both strains were shed at comparable levels on days 1--4 after infection (data not shown).Figure 8**EspH contributes to EPEC persistence in the mouse gut, DSG2 redistribution, and disruption of mouse intestinal epithelial cell junctions.** C57BL/6J mice were mock-treated or infected with EPEC or SE874. (*A*) Colonization of the cecum and colon on days 3 and 4 after infection (N = 4 per sample group) were evaluated by plating on selective media. *Horizontal line* represents median. *P* values were computed using analysis of variance with the Bonferroni post hoc test. Colon tissues of mock-treated or day 3 postinfected mice (N = 4 per sample group) were used for (*B*) immunofluorescence staining and (*C*) transmission electron microscopy experiments. (*A*) *Blue boxes* correspond to representative tissue samples of infected animals shown in panels *B* and *C*. (*B*) Colon tissues of mock-treated, EPEC-infected or SE874-infected mice were stained for DSG2 (magenta) and 4,6-diamidino-2-phenylindole (blue). *Arrows* point to punctate cytoplasmic DSG2 staining. Images were captured using the DeltaVision Elite Deconvolution Microscope equipped with an Olympus 40×/1.35 oil objective and using immersion oil (n = 1.516). *Scale bar*: 17 μm. (*C*) Transmission electron micrographs of colon tissues of mock-treated (*left panel*), EPEC-infected (*middle panel*), or SE874-infected (*right panel*) showing tight junctions (*magenta arrowheads*) and areas of unzipping and separation of lateral membranes (*blue arrows*). *Scale bar*: 500 nm. All immunofluorescence and transmission electron microscopy images are representative of at least 6 fields captured per sample from the 3 sample groups (n = 4 per sample group). CFU, colony-forming unit.

To investigate infection-induced DSG2 alterations in vivo, colonic tissues isolated on day 3 after infection, when WT EPEC and SE874 colonized at comparable levels, were subjected to immunofluorescence staining. In uninfected and SE874*-*infected mice, DSG2 was distributed uniformly along the colonic epithelial cell junctions ([Figure 8](#fig8){ref-type="fig"}*B*). In colon tissues of EPEC-infected mice, however, DSG2 was relocalized intracellularly into distinct puncta, consistent with our in vitro observations. Electron micrographs images of infected tissues showed separation of the lateral membranes of colonic epithelial cells in WT-infected mice, but not mock-treated or SE874-infected animals ([Figure 8](#fig8){ref-type="fig"}*C*). Notably, as previously seen in infant colon biopsy specimens,[@bib19] and in vitro ([Figure 4](#fig4){ref-type="fig"}*B*), basolateral unzipping was evident in EPEC-infected mice even in areas where the TJs appeared unperturbed. Collectively, these data suggest that EspH mediates EPEC-induced DSG2 relocalization from intestinal epithelial junctions, its subsequent loss in the cytosol, and the consequent perturbation of cell--cell contacts. These changes likely contribute to EPEC colonization of the mouse intestine.

Discussion {#sec3}
==========

As its primary virulence strategy, EPEC secretes effector proteins into IECs and alters their physiology.[@bib12] We show that the RhoGEF-sequestering effector EspH inhibits RhoA activity and, correspondingly, induces the internalization and degradation of DSG2 and its major heterotypic partner, DSC2. This results in the loss of desmosomal contacts between adjacent cells, weakened cell--cell adhesion, and disruption of epithelial barrier function. The loss of desmosomal contacts could be a precursor to the cell rounding phenotype observed in EspH-expressing cells,[@bib29], [@bib42] and the epithelial erosion previously seen in infected animal tissues.[@bib43] Importantly, the mechanism outlined for EspH-dependent DSG2 depletion and desmosomal perturbation may provide a molecular basis for the basolateral junction widening observed in intestinal biopsy specimens from EPEC-infected infants.[@bib19]

Rho GTPases were implicated in the maintenance of desmosomal integrity of keratinocytes and myocardial cells,[@bib30], [@bib44], [@bib45], [@bib46] but their impact on desmosomes of the very different simple columnar intestinal epithelia is unknown. On the other hand, the effects of Rho GTPase signaling on intestinal epithelial TJs and adherens junctions have been characterized in some detail.[@bib47] Our studies provide 2 lines of evidence for a key role for Rho GTPase signaling in maintaining IEC desmosomal junctions: EspH mutants that failed to inhibit RhoA also were unable to perturb desmosomes, and CN03-mediated Rho GTPase activation rescued EPEC-induced DSG2 loss.

EspH-induced Rho GTPase inhibition leads to actin cytoskeleton disruption[@bib29]; our studies also implicate a role for EspH in perturbing the IF network. Our observations are consistent with a model whereby EspH-mediated Rho GTPase inactivation impedes the actin-dependent, inward-directed transport of cytokeratins from the periphery to the cell center, leading to IF retraction[@bib35], [@bib36]; this, possibly in conjunction with displacement of the IF-desmosome linker, desmoplakin, induces DSG2 internalization into, and degradation in, lysosomes.[@bib33], [@bib34] We previously described cytokeratin alterations in EPEC-infected cells partially mediated by EspF.[@bib48] EspF therefore also may contribute to desmosomal perturbations. However, given the profound deficiency of cytokeratin and DSG2 perturbations in cells infected with SE874 (which lacks EspH, but expresses EspF), EspF may have only an ancillary role in this process.

Desmosomal perturbations have been reported in the context of other intestinal infections, notably with *Entamoeba histolytica*, *Giardia duodenalis*, and *Campylobacter jejuni*.[@bib49], [@bib50], [@bib51] *E histolytica* EhCP112 protease cleaves several desmosomal proteins, including DSG2, but the underlying mechanisms for *C jejuni*-- and *G duodenalis*--mediated desmosomal perturbation are unknown. The current study is a mechanistic characterization of Rho-dependent intestinal epithelial desmosomal perturbation. By extension, other enteric pathogens that harbor Rho GTPase-inactivating virulence proteins, such as *Clostridium difficile* (toxins TcdA and TcdB),[@bib52] *Vibrio cholerae* (MARTX toxin),[@bib53] and *Yersinia* (YopE, YpkA, and YopT)[@bib54] may also promote desmosome destabilization. Beyond a possible role in the etiology of infectious diseases, a robust decrease in DSG2 levels was observed in the mucosa of patients with Crohn's disease.[@bib45] It is noteworthy that there was an increased abundance of specific pathogenic *E coli* strains in a subset of Crohn's disease patients; many of these strains disrupt epithelial barrier function, but their impacts on desmosomal junctions have not been explored.[@bib55]

Our work now adds EspH to the list of EPEC effector proteins that perturb epithelial paracellular permeability.[@bib56] The impact of EspH on epithelial barrier function is novel and noteworthy because it suggests a role for desmosomes beyond that of inert scaffolding. Consistent with this hypothesis, small interfering RNA--mediated DSG2 down-regulation in IECs alters epithelial barrier function.[@bib45] Interestingly, a tandem peptide-mediated stabilization of junctional DSG2 linkages in Caco-2 cells ameliorated TNF-α--induced barrier disruption.[@bib45] Electron micrographs images of EPEC-infected epithelial cells suggest that DSG2 depletion and separation of lateral cell surfaces precede complete dissociation of TJs. Our data, however, do not rule out the possibility of a direct impact of EspH-mediated Rho inhibition on TJs, independent of, and in addition to, the desmosomal alterations.

In contrast to our observations, Guttman et al[@bib57] noted that desmoglein and desmocollin remain unchanged during EPEC infection in vitro. The differences in experimental conditions between the 2 studies is a likely explanation for this discrepancy. Whereas Guttman et al[@bib57] used subconfluent Caco-2 cells, our studies used confluent C2~BBe~ cells that reportedly have maximal cell-junctional DSG2 distribution and stable desmosomes.

Interestingly, Guttman et al[@bib57] also did not detect desmoglein redistribution in colonic tissues of mice infected with *Citrobacter rodentium*. This may well represent a true distinction between EPEC and *C rodentium*. Unlike the prototype EPEC strain used in this study, *C rodentium* secretes EspM2 and EspT, which mimic GEF activity for RhoA and Rac1, respectively. These effectors were shown to mitigate some impacts of EspH-mediated Rho GTPase suppression.[@bib29], [@bib58], [@bib59], [@bib60] Consistent with this, *C rodentium* mutants lacking *espH* were not impaired for virulence in mouse infection studies, although they fared poorer in competition experiments with WT *C rodentium*.[@bib61] In contrast, EPEC mutants lacking *espH* initially colonized the mouse cecum and colon at levels comparable with the parent WT strain (3 days after infection) but were recovered at lower levels on day 4 after infection. EspH-induced barrier perturbations may enhance nutrient flux into the intestine, which, in turn, may facilitate EPEC expansion; alternatively, the concomitant activation of inflammatory responses may deplete commensal organisms and provide EPEC a competitive edge. In a previous study, enterohemorrhagic *E coli* mutants lacking *espH* also were shown to be impaired for virulence in a rabbit model of infection.[@bib62]

A comprehensive understanding of the role of EspH, as well as Rho GTPase inhibition and desmosomal changes in A/E pathogen virulence, therefore, requires due consideration of the specific model systems, and an appreciation for the cooperative action of effector molecules. In summary, we identified a novel role for EPEC EspH in perturbing intestinal epithelial desmosomal junctions, which likely contributes to disease. Our delineation of the underlying pathway of desmosomal disruption, involving Rho GTPases and the actin cytoskeleton, has broader implications for both normal intestinal function and for various pathologic states.
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